Active — Not RecruitingNot Applicable

Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

United States115 participantsStarted 2024-03-11

Plain-language summary

The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.

Who can participate

Age range2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to provide informed consent (adults 18 and above) and assent if seven or above. Legally authorized representative (LAR) is able to provide consent in case of minors or in case of adults unable to consent.
✓. Children \> 2 years and adults at elevated risk of developing (or having misdiagnosed) clinically evident Stage 3 T1D because they have at least one of the following:
✓. Resides in the following Counties: Orange, Seminole, Osceola, Lake, Volusia, Brevard, Polk, Hillsborough.

Exclusion criteria

✕. People with a diagnosis of type stage 3T1D or T1D clinical definition per ADA Standards of Care
✕. History of organ transplant
✕. Be deemed unable or unlikely to comply with the protocol.
✕. Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete study visit/s.

What they're measuring

Blood sample will be drawn for islet-related autoantibodies

Timeframe: Visit 1 (1 day, 1-2 hours)- Only visit for the entire study.

Trial details

NCT IDNCT06908057

SponsorAdventHealth Translational Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Type 1 Diabetes trials